This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Covid-19
UK study suggests that the risk of re-infection with COVID-19 is low
Read more
Neutralisation of N501Y mutant strain of COVID-19 by BNT162b2 vaccine
Read more
Tocilizumab and sarilumab improve survival in REMAP-CAP study
Read more
Study confirms efficacy of the BNT162b2 COVID-19 vaccine
Read more
Analysis of recent COVID-19 variant reveals a greater potential for binding to ACE2
Read more
Nearly a third of COVID-19 survivors readmitted to hospital within 60 days
Read more
Neurological symptoms in COVID-19 patients lead to higher in-hospital mortality
Read more
Uncertainty over whether COVID-19 leads to ocular symptoms
Read more
AZD1222 vaccine has acceptable efficacy and safety profile
Read more
Approximately a fifth of people across the world would refuse a COVID-19 vaccine
Read more
Differences in immune and clotting functioning may explain less severe COVID-19 in children
Read more
Nutritional supplements potentially beneficial in COVID-19
Read more
Low BMI increases risk of death with COVID-19
Read more
Latest REACT-1 study data suggest COVID-19 rates are falling
Read more
Prior bariatric surgery associated with better outcomes in patients with COVID-19
Read more
No increased risk for transmission with COVID-19 mutations
Read more
FDA approves baricitinib remdesivir combination for COVID-19
Read more
Page 19 of 27
« First
«
...
10
...
17
18
19
20
21
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Telemedicine strategy post-acute coronary syndrome drives efficiencies and safety, study finds
17 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
x
Search for: